Pages that link to "Q24793791"
Jump to navigation
Jump to search
The following pages link to Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634] (Q24793791):
Displayed 23 items.
- Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis (Q24186852) (← links)
- Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management (Q26744040) (← links)
- Managing Sleep Disturbances in Cirrhosis (Q26744541) (← links)
- Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) (← links)
- Concept on the pathogenesis and treatment of primary biliary cirrhosis (Q33866454) (← links)
- Fatigue in primary biliary cirrhosis (Q34114608) (← links)
- Primary sclerosing cholangitis: diagnosis and management (Q34498568) (← links)
- Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience (Q34904107) (← links)
- Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort (Q35760389) (← links)
- Physical fitness, fatigue, and quality of life after liver transplantation (Q35880773) (← links)
- Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. (Q36335752) (← links)
- Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output (Q36532545) (← links)
- Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. (Q38738566) (← links)
- Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. (Q38833243) (← links)
- Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis (Q39177947) (← links)
- Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid (Q46102659) (← links)
- Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment (Q48853559) (← links)
- The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. (Q54976907) (← links)
- Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis. (Q55498617) (← links)
- Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review (Q61856283) (← links)
- The medical management of primary sclerosing cholangitis (Q81194314) (← links)
- Primary biliary cirrhosis (Q84230884) (← links)
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis (Q92465727) (← links)